Wayne Brisbane MD (He/Him)
Surgical Oncology
Assistant Professor University of California, Los Angeles Department of Urology
Join to view full profile
200 UCLA Medical PlazaSuite 140Los Angeles, CA 90095
Phone+1 310-794-3070
Fax+1 310-794-3070
Dr. Brisbane is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Wayne Brisbane is a Urologist with a subspecialty in Surgical Oncology, based in Los Angeles, CA. He completed his fellowship in Urologic Surgical Oncology at UCLA and his residency in Urology at the University of Washington. Dr. Brisbane is currently an Assistant Professor at UCLA Health and a Research Scientist at Ronald Reagan UCLA Medical Center. His clinical expertise includes prostate cancer, chronic pelvic pain, female sexual dysfunction, pelvic organ prolapse, and metabolic stone disease. He has several publications focusing on prostate cancer and the use of artificial intelligence in treatment and diagnosis, and he is also involved in clinical trials optimizing prostate biopsy techniques.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Urologic Surgical Oncology, 2019 - 2021
University of WashingtonResidency, Urology, 2015 - 2019
Loma Linda University School of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2019 - 2027
FL State Medical License 2021 - 2023
WA State Medical License 2013 - 2019
AK State Medical License 2017 - 2018
American Board of Urology Urology
Clinical Trials
- Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI Start of enrollment: 2021 Dec 15
Roles: Contact
Publications & Presentations
PubMed
- Micro-ultrasound super-resolution with geometry-driven consistency models.Kaifeng Pang, Kai Zhao, Qi Miao, Alex Ling Yu Hung, Changsuk Oh
Medical Image Analysis. 2027-01-01 - Lu-Prostate-specific Membrane Antigen Prior to Stereotactic Ablative Radiotherapy in Oligorecurrent Prostate Cancer: Secondary and Exploratory End Point Results from t...Amar U Kishan, Holly Wilhalme, Carol Felix, Johanna Enke, Farzana Z Ali
European Urology. 2026-10-12 - 1 citationsHead-to-head Comparison of Multimodal Imaging for Prostate Cancer Detection and Local Staging with Whole-mount Histopathology Reference.Qi Miao, Anthony Sisk, Ida Sonni, Kyla Grunden, Vinicius Ludwig
European Urology Oncology. 2026-10-01
Press Mentions
UCLA Investigators Highlight Innovations in Prostate and Bladder Cancer, AI, and Patient-Centered Care at Aua 2025April 22nd, 2025- UCLA Study: AI Helps Predict Success of Prostate Cancer TreatmentMarch 18th, 2025
- AI Tool Predicts Patients Most Likely to Benefit from Focal Therapy for Prostate CancerMarch 18th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
